Medication info

DuoWell A Plus Tablet 80/10/10/5 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets/box [6 tablets/PTP x 5]
Approval status
Active

MFDS item code 202202137 · Approved 2022.05.20

Summary

Main use
Treatment of hypertension and dyslipidemia (including hypercholesterolemia)
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Take this medicine whole; do not chew, split, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering the telmisartan/amlodipine combination. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, the recommended treatment goal, and the patient's response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg–20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After initiating treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 20/10mg once daily. Patients taking the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Treatment of hypertension and dyslipidemia (including hypercholesterolemia)

  • Essential hypertension
  • primary hypercholesterolemia
  • familial heterozygous hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients who need to take both the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination simultaneously. It is primarily designed for patients with essential hypertension not adequately controlled and those with dyslipidemia. This medication helps improve blood pressure in patients whose hypertension is difficult to manage and lowers bad cholesterol levels in patients with hypercholesterolemia and mixed dyslipidemia, thereby aiding cardiovascular health. It also works to increase good cholesterol (HDL-C) to overall improve lipid conditions in the blood. This medication is effectively used for managing both of these conditions together.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Take this medicine whole; do not chew, split, or crush it. ○ Telmisartan/amlodipine The recommended dose of the telmisartan/amlodipine combination is once daily. It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering the telmisartan/amlodipine combination. However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or the telmisartan/amlodipine combination 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In elderly patients aged 75 years and older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually. ○ Rosuvastatin/ezetimibe Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, the recommended treatment goal, and the patient's response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg–20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After initiating treatment with the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 20/10mg once daily. Patients taking the telmisartan/amlodipine combination and the rosuvastatin/ezetimibe combination concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may pose a serious risk to the fetus if used during pregnancy, so it should not be used by women who are pregnant or may become pregnant. This medication should not be administered to patients with severely impaired liver function or certain liver diseases, and regular liver function tests are required. It is also advisable for patients with severely poor kidney function or specific kidney diseases to avoid this medication. Patients with muscle diseases or those at high risk for muscle-related side effects should use this medication with caution, and if symptoms such as muscle pain or weakness occur, they should consult a doctor immediately. This medication should not be given to patients allergic to certain ingredients, and those with genetic metabolic disorders such as lactose intolerance should be cautious. During the use of this medication, blood pressure may drop too low, so if symptoms of hypotension appear, they should immediately inform the healthcare provider. Due to the risk of hyperkalemia, meaning increased potassium levels in the blood, regular blood tests are needed for monitoring, especially when taken with potassium supplements or potassium-containing medications. This medication may affect liver and kidney function, so if liver dysfunction or kidney impairment is suspected, the medical provider should be informed immediately, and regular testing may be necessary. If symptoms such as muscle pain, fatigue, or fever develop, they should inform the doctor immediately and get tested, as in severe cases the medication may need to be discontinued. This medication can interact with other drugs; therefore, if the patient is taking other medications, they must inform the healthcare provider, especially when used in conjunction with blood pressure medications, anticoagulants, antibiotics, and analgesics. Caution should be exercised as dizziness or drowsiness may occur during driving or operating machinery. Patients with heart failure or cardiovascular disease should use this medication with extra caution, and if symptoms worsen, they should consult their healthcare provider immediately. While taking this medication, regular monitoring of blood pressure, blood tests, liver function tests, and kidney function tests is necessary to check for abnormalities. If any adverse reactions are suspected while taking this medication, they should inform the healthcare provider immediately and obtain the proper intervention.

Side effects

Eyelid damage, head injury, dysuria, flushing, chronic gastritis, various gastrointestinal disorders, hiatal hernia, facial swelling, unusual sensation, drug intolerance, chest pain, irritable bowel syndrome, colon polyps, esophagitis, dizziness, drowsiness, neurodegenerative disorder, postural dizziness, migraine, diabetes, glucose tolerance impairment, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue inflammation, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, eyelid ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, upper respiratory tract infection, urinary tract infection, septicemia, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, liver dysfunction, liver impairment, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, asthenia, influenza-like illness, increased serum creatinine, elevated serum uric acid, increased liver enzymes, raised serum creatine kinase, decreased hemoglobin, angioedema, hypoglycemia, vasculitis, increased tension, sensory reduction, sensory abnormalities, peripheral neuropathy, taste abnormalities, tremors, extrapyramidal disorder, erectile dysfunction, change in bowel habits, gingival hyperplasia, pancreatitis, nausea, headache, facial spasm, sensory abnormalities, paralysis, hyperventilation, pneumonia, erectile dysfunction, edema, fatigue, weight gain, weight loss, thrombocytopenia, urticaria, hyperhidrosis, purpura, skin discoloration, toxic epidermal necrolysis, conjunctivitis, tinnitus, petechiae, polyneuropathy, memory impairment, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug reaction syndrome with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, arthralgia, myalgia, elevated creatine phosphokinase, myopathy, rhabdomyolysis, increased liver aminotransferase levels, hepatitis, cholelithiasis, cholecystitis, influenza-like illness, tremor, epigastric pain, gastritis, dry mouth, discomfort in the epigastrium, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, blood pressure reduction, sinoatrial block, atrioventricular block, precordial pain, loose stools, constipation, skin flushing, maculopapular rash, heaviness, warmth, impaired glucose tolerance, asthenia, hepatitis, jaundice, elevated liver enzyme levels, palpitations, fatigue, nausea, headache, dizziness, cough, dyspepsia, palpitations, vertigo, drowsiness, abdominal pain, nausea, weakness, fatigue, vasculitis, increased tension, sensory reduction, sensory abnormalities, peripheral neuropathy, syncope, taste abnormalities, tremors, extrapyramidal disorder, erectile dysfunction, gynecomastia, increased frequency of urination, urination disorders, nocturia, hepatitis, jaundice, elevated liver enzyme levels, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, blood pressure reduction, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin flushing, maculopapular rash, heaviness, warmth, impaired glucose tolerance, asthenia, angioedema, thrombocytopenia, increased serum creatinine, acute renal failure, oliguria, myalgia, arthralgia, headache, increased ALT, increased CK, constipation, increased AST, asthenia, fatigue, numbness, sensory abnormalities, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and should be kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets/box [6 tablets/PTP x 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.